↓ Skip to main content

Cochrane Database of Systematic Reviews

Sildenafil for pulmonary hypertension in neonates.

Overview of attention for article published in Cochrane database of systematic reviews, August 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
68 Mendeley
connotea
1 Connotea
Title
Sildenafil for pulmonary hypertension in neonates.
Published in
Cochrane database of systematic reviews, August 2011
DOI 10.1002/14651858.cd005494.pub3
Pubmed ID
Authors

Shah PS, Ohlsson A, Shah, Prakeshkumar S, Ohlsson, Arne

Abstract

Persistent pulmonary hypertension in neonates (PPHN) is associated with high mortality. Currently, the therapeutic mainstay for PPHN is assisted ventilation and administration of inhaled nitric oxide (iNO). However, nitric oxide is costly and may not be appropriate in resource-poor settings. Approximately 30% of patients fail to respond to iNO. High concentrations of phosphodiesterases in the pulmonary vasculature has led to the use of phosphodiesterase inhibitors such as sildenafil or milrinone.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 3%
South Africa 1 1%
Unknown 65 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 15%
Student > Master 9 13%
Student > Bachelor 8 12%
Other 7 10%
Student > Postgraduate 5 7%
Other 13 19%
Unknown 16 24%
Readers by discipline Count As %
Medicine and Dentistry 37 54%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Social Sciences 2 3%
Psychology 1 1%
Other 3 4%
Unknown 18 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2016.
All research outputs
#6,000,719
of 22,651,245 outputs
Outputs from Cochrane database of systematic reviews
#7,817
of 12,296 outputs
Outputs of similar age
#34,043
of 120,634 outputs
Outputs of similar age from Cochrane database of systematic reviews
#60
of 105 outputs
Altmetric has tracked 22,651,245 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 12,296 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 120,634 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.